ATP13A2 Antikörper (AA 1001-1080) (FITC)
-
- Target Alle ATP13A2 Antikörper anzeigen
- ATP13A2 (ATPase Type 13A2 (ATP13A2))
-
Bindungsspezifität
- AA 1001-1080
-
Reaktivität
- Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ATP13A2 Antikörper ist konjugiert mit FITC
-
Applikation
- Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Ratte
- Homologie
- Human,Mouse,Cow,Pig,Horse,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human ATP13A2
- Isotyp
- IgG
- Top Product
- Discover our top product ATP13A2 Primärantikörper
-
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- ATP13A2 (ATPase Type 13A2 (ATP13A2))
- Andere Bezeichnung
- PARK9/ATP13A2 (ATP13A2 Produkte)
- Synonyme
- ATP13A2 antikoerper, 1110012E06Rik antikoerper, AA589443 antikoerper, RGD1307977 antikoerper, im:7147302 antikoerper, zgc:136762 antikoerper, CLN12 antikoerper, HSA9947 antikoerper, KRPPD antikoerper, PARK9 antikoerper, ATPase 13A2 antikoerper, ATPase type 13A2 antikoerper, probable cation-transporting ATPase 13A2 antikoerper, ATP13A2 antikoerper, Atp13a2 antikoerper, atp13a2 antikoerper, PTRG_01071 antikoerper, MCYG_01937 antikoerper, LOC100439053 antikoerper
- Hintergrund
-
Synonyms: AT132_HUMAN, Atp13a2, ATPase type 13A2, CLN12, HSA9947, KRPPD, PARK9, Probable cation transporting ATPase 13A2, Probable cation-transporting ATPase 13A2, Putative ATPase, RP1-37C10.4.
Background: ATP13A2 is a 1,180 amino acid multi-pass membrane protein that belongs to the P5 subfamily of ATPases which play an important role in the transportation of inorganic cations. Expressed as multiple alternative spliced isoforms, ATP13A2 functions to catalyze the conversion of ATP to ADP and a free phosphate, thereby participating in the active transport of ions across cellular membranes. Defects in the gene encoding ATP13A2 are the cause of Kufor-Rakeb syndrome (KRS), a rare hereditary type of Parkinson?s disease that exhibits juvenile onset and is characterized by neurodegeneration and dementia. The ATP13A2 gene maps to human chromosome 1, which spans 260 million base pairs, contains over 3,000 genes and comprises nearly 8 % of the human genome.
- Pathways
- Ribonucleoside Biosynthetic Process
-